A Phase II Open Label Trial of PF-00299804 Monotherapy in Patients With HER-2 Positive Advance Gastric Cancer After Failure of At Least One Prior Chemotherapy Regimen.
Phase of Trial: Phase II
Latest Information Update: 24 Nov 2015
At a glance
- Drugs Dacomitinib (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 19 May 2015 Status changed from not yet recruiting to completed as per ClinicalTrials.gov record.
- 30 Jun 2010 New trial record